TROP-2 directed Antibody-Drug Conjugates (ADCs): the revolution of smart drug delivery in advanced Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer (NSCLC) is the leading cause of cancer death in both male and female worldwide, accounting for nearly 20% of all cancer deaths in Europe. [1,2]
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Tags: Systematic or Meta-analysis Studies Source Type: research